AFYREN (FR:ALAFY)

:ALAFY

ALAFY

AFYREN

RESEARCH TOOLSreports

Want to see FR:ALAFY full AI Analyst Report?

AFYREN (ALAFY) Price & Analysis

1 Followers

ALAFY Stock Chart & Stats

€2.85

-€0.20(-8.37%)

At close: Jan 09 4:00 PM EST

€2.85

-€0.20(-8.37%)

Day’s Range― - ―

52-Week Range€1.61 - €3.28

Previous CloseN/A

Volume19.43K

Average Volume (3M)10.93K

Market Cap

€90.91M

Enterprise Value€30.58M

Total Cash (Recent Filing)€35.16M

Total Debt (Recent Filing)€2.42M

Price to Earnings (P/E)―

Beta0.18

Next Earnings

Sep 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.26

Shares Outstanding38,852,520

10 Day Avg. Volume15,238

30 Day Avg. Volume10,926

Financial Highlights & Ratios

PEG Ratio-0.12

Price to Book (P/B)1.22

Price to Sales (P/S)33.31

P/FCF Ratio-14.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.26

Revenue Forecast (FY)€2.90M

Bulls Say, Bears Say

Bulls Say

Low Leverage / Strong Equity BaseA materially lower debt load and a sizeable equity base give AFYREN structural financial flexibility. Low leverage reduces insolvency risk during multi-year scaling, supports the ability to raise capital on reasonable terms, and buys time to commercialize plants and convert contracts into recurring cash flow.

Diversified, Renewable End-Market ExposureAFYREN’s products serve multiple end markets with structurally growing demand for renewable ingredients. Broad industry exposure reduces single-market dependence, improving resilience versus commodity cycles and enabling cross-market commercialization of fermentation-derived acids.

Proven Positive Unit Economics HistoricallyThe company recorded positive gross profit in prior years, indicating its fermentation process can yield acceptable unit economics at certain scales or product mixes. That historical proof point implies operational fixes or volume growth could restore margins if cost structure and utilization are addressed.

Bears Say

Shrinking Revenue And Widening LossesSustained declines in top-line and materially larger net losses weaken the company's ability to attain scale economies and fund industrial projects internally. Persistent revenue contraction undermines commercial traction and raises long-term questions about demand capture and the pathway to sustainable profitability.

Consistent Negative Operating & Free Cash FlowOngoing negative operating and free cash flow means AFYREN cannot self-fund expansion or cover losses, necessitating external financing. Reliance on new capital increases dilution or refinancing risk and constrains investment in commercialization, delaying the timeline to profitable, cash-generative operations.

Deteriorating Returns On EquityNegative and worsening ROE indicates invested capital is not producing sufficient economic returns. Over time this erodes shareholder value and signals structural issues in converting technology and assets into profitable sales unless margins, pricing power, or utilization materially improve.

ALAFY FAQ

What was AFYREN’s price range in the past 12 months?

AFYREN lowest stock price was €1.61 and its highest was €3.28 in the past 12 months.

What is AFYREN’s market cap?

AFYREN’s market cap is €90.91M.

When is AFYREN’s upcoming earnings report date?

AFYREN’s upcoming earnings report date is Sep 30, 2026 which is in 152 days.

How were AFYREN’s earnings last quarter?

AFYREN released its earnings results on Mar 31, 2026. The company reported -€0.264 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.264.

Is AFYREN overvalued?

According to Wall Street analysts AFYREN’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AFYREN pay dividends?

AFYREN does not currently pay dividends.

What is AFYREN’s EPS estimate?

AFYREN’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AFYREN have?

AFYREN has 38,852,520 shares outstanding.

What happened to AFYREN’s price movement after its last earnings report?

AFYREN reported an EPS of -€0.264 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.099%.

Which hedge fund is a major shareholder of AFYREN?

Currently, no hedge funds are holding shares in FR:ALAFY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AFYREN

AFYREN SAS, a sustainable chemical company, produces biomolecules derived from the recycling of non-food biomass, primarily used in human and animal nutrition, flavors and fragrances, life sciences, materials sciences, and lubricants sectors. It offers biosourced organic acids, such as acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, and caproic acid. The company was incorporated in 2012 and is headquartered in Clermont-Ferrand, France.